Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1862-1867

  Badaru, Angela ^a   Wilson, Darrell M ^a   Bachrach, Laura K ^a   Fechner, Patricia ^a   Gandrud, Laura M ^a   Durham, Eileen ^a   Wintergerst, Kupper ^a   Chi, Carolyn ^a   Klein, Karen O ^b   Neely, E Kirk ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LABORATORY TEST; MALE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL;

CHILD; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; MALE; PUBERTY, PRECOCIOUS; REPRODUCIBILITY OF RESULTS;

EID: 33646394328     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1500     Document Type: Article

References (20)

1. Tanaka T, Hibi I, Kato K, Saito S, Shimizu N, Suwa S, Nakajima H 1991 A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group. Endocrinol Jpn 38:369-376
2. Carel JC, Lahlou N, Guazzarotti L, Joubert-Collin M, Roger M, Colle M, Chaussain JL 1995 Treatment of central precocious puberty with depot leuprorelin. French Leuprorelin Trial Group. Eur J Endocrinol 132:699-704
3. Carel JC, Lahlou N, Jaramillo O, Montauban V, Teinturier C, Colle M, Lucas C, the French Leuprorelin Trial Group, Chaussain JL 2002 Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). J Clin Endocrinol Metab 87:4111-4116
4. Neely EK, Hintz RL, Wilson DM, Lee PA, Gautier T, Argente J, Stene M 1995 Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr 127:40-46
5. Bull RK, Edwards PD,KempPM, Fry S, Hughes IA 1999 Bone age assessment: a large scale comparison of the Greulich and Pyle, and Tanner and Whitehouse (TW2) methods. Arch Dis Child 81:172-173
6. Bhatia S, Neely EK, Wilson DM 2002 Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy. Pediatrics 109:E30
7. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler Jr GB 1994 Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 94:2475-2480
8. Parker KL, Baens-Bailon RG, Lee PA 1991 Depot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab 73:50-52
9. Cook JS, Doty KL, Conn PM, Hansen JR 1992 Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab 74:1206-1209
10. Eckert KL, Wilson DM, Bachrach LK, Anhalt H, Habiby RL, Olney RC, Hintz RL, Neely EK 1996 A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics 97:517-519
11. Periti P, Mazzei T, Mini E 2002 Clinical pharmacokinetics of depot leuprorelin. Clin Pharmacokinet 41:485-504
12. Mazzei T, Mini E, Eandi M, Reali EF, Fioretto L, Bartoletti R, Rizzo M, Calabro G, Periti P 1989 Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. Drugs Exp Clin Res 15:373-387
13. Mazzei T, Mini E, Rizzo M, Periti P 1990 Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. J Int Med Res 18(Suppl 1):42-56
14. Khan MS, O'Brien A 1998 An evaluation of pharmacokinetics and pharmacodynamics of leuprorelin acetate 3M-depot in patients with advanced and metastatic carcinoma of the prostate. Urol Int 60:33-40
15. Tunn UW, Bargelloni U, Cosciani S, Fiaccavento G, Guazzieri S, Pagano F 1998 Comparison of LH-RH analogue 1-month depot and 3-month depot by their hormone levels and pharmacokinetic profile in patients with advanced prostate cancer. Urol Int 60(Suppl 1):9-16
16. Garibaldi LG, Aceto T, Webber C, Pang S 1993 The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test. J Clin Endocrinol Metab 76:851-856
17. Ibanez L, Potau N, Zampolli M, Virdis R, Gussinye M, Carrascosa A, Saenger P, Vicens-Calvet E 1994 Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab 78:30-35
18. Brito VN, Latronico AC, Arnhold IJP, Mendonca BB 2004 A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls. J Clin Endocrinol Metab 89:4338-4342
19. Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A 2000 Diurnal rhythms of luteinizing hormone, follicle stimulating hormone, testosterone, and estradiol secretion before the onset of female puberty in short children. J Clin Endocrinol Metab 85:1074-1080
20. Lampit M, Golander A, Guttmann H, Hochberg Z 2002 Estrogen mini-dose replacement during GnRH agonist therapy in central precocious puberty: a pilot study. J Clin Endocrinol Metab 87:687-690